The Pharmaceutical Triple Aim
Higher Medication Adherence Increases Revenue and EPS for Pharma, Improves Patient Outcomes and Lowers Healthcare Costs
The numbers in HealthPrize’s newest investigative report tell the story: higher adherence can have a significant impact on pharma’s EPS growth, and it can do so relatively quickly.
Find out how your company ranked: get the report →
HealthPrize, the leading cloud-based patient experience and adherence platform for life science companies, uses gamification, behavioral economics and loyalty marketing to deliver mean adherence lifts of 52% across all drugs, diseases, demographics and dosages.
20 Marshall Street, Ste. 220, Norwalk, CT 06854
